Page last updated: 2024-11-08

amifampridine and Amnesia

amifampridine has been researched along with Amnesia in 1 studies

Amifampridine: 4-Aminopyridine derivative that acts as a POTASSIUM CHANNEL blocker to increase release of ACETYLCHOLINE from nerve terminals. It is used in the treatment of CONGENITAL MYASTHENIC SYNDROMES.

Amnesia: Pathologic partial or complete loss of the ability to recall past experiences (AMNESIA, RETROGRADE) or to form new memories (AMNESIA, ANTEROGRADE). This condition may be of organic or psychologic origin. Organic forms of amnesia are usually associated with dysfunction of the DIENCEPHALON or HIPPOCAMPUS. (From Adams et al., Principles of Neurology, 6th ed, pp426-7)

Research Excerpts

ExcerptRelevanceReference
"The effects of three K(+) channel blockers, 4-aminopyridine, 3, 4-diaminopyridine and apamin, on scopolamine- or electroconvulsive shock-induced amnesia were investigated in mice by using a one-trial step-down passive avoidance system."3.70The effects of some K(+) channel blockers on scopolamine- or electroconvulsive shock-induced amnesia in mice. ( Aksu, F; Baysal, F; Inan, SY, 2000)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Inan, SY1
Aksu, F1
Baysal, F1

Other Studies

1 other study available for amifampridine and Amnesia

ArticleYear
The effects of some K(+) channel blockers on scopolamine- or electroconvulsive shock-induced amnesia in mice.
    European journal of pharmacology, 2000, Oct-27, Volume: 407, Issue:1-2

    Topics: 4-Aminopyridine; Amifampridine; Amnesia; Animals; Apamin; Avoidance Learning; Electroshock; Male; Mi

2000